End-of-day quote
Shenzhen S.E.
07:00:00 2023-03-13 pm EDT
|
5-day change
|
1st Jan Change
|
20.96
CNY
|
-0.33%
|
|
-.--%
|
-.--%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,301
|
6,688
|
6,621
|
5,989
|
4,050
|
-
|
-
|
Enterprise Value (EV)
1 |
3,301
|
6,688
|
6,621
|
5,989
|
4,050
|
4,050
|
4,050
|
P/E ratio
|
28.4
x
|
35.5
x
|
35.8
x
|
-31.8
x
|
39.8
x
|
9.32
x
|
17.6
x
|
Yield
|
-
|
0.87%
|
0.99%
|
-
|
0.73%
|
0.61%
|
1.7%
|
Capitalization / Revenue
|
-
|
4.38
x
|
4.13
x
|
4.46
x
|
2.18
x
|
1.08
x
|
1.32
x
|
EV / Revenue
|
-
|
4.38
x
|
4.13
x
|
4.46
x
|
2.18
x
|
1.08
x
|
1.32
x
|
EV / EBITDA
|
-
|
-
|
-
|
-139
x
|
4.48
x
|
3.3
x
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
4.22
x
|
3.82
x
|
4.03
x
|
2.55
x
|
1.7
x
|
2.13
x
|
Nbr of stocks (in thousands)
|
285,629
|
327,258
|
327,958
|
327,958
|
327,958
|
-
|
-
|
Reference price
2 |
11.56
|
20.44
|
20.19
|
18.26
|
12.35
|
12.35
|
12.35
|
Announcement Date
|
4/14/21
|
4/24/22
|
4/24/23
|
4/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
1,526
|
1,602
|
1,344
|
1,862
|
3,745
|
3,067
|
EBITDA
1 |
-
|
-
|
-
|
-43.02
|
904
|
1,229
|
-
|
EBIT
1 |
-
|
217.7
|
223.4
|
-177.8
|
130
|
604.5
|
281
|
Operating Margin
|
-
|
14.26%
|
13.94%
|
-13.23%
|
6.98%
|
16.14%
|
9.16%
|
Earnings before Tax (EBT)
1 |
-
|
216.1
|
222.7
|
-179.5
|
121
|
600
|
272
|
Net income
1 |
118.4
|
173.7
|
184.9
|
-188.2
|
103
|
436.2
|
231
|
Net margin
|
-
|
11.38%
|
11.54%
|
-14.01%
|
5.53%
|
11.65%
|
7.53%
|
EPS
2 |
0.4069
|
0.5764
|
0.5640
|
-0.5738
|
0.3100
|
1.325
|
0.7000
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.1786
|
0.2000
|
-
|
0.0900
|
0.0750
|
0.2100
|
Announcement Date
|
4/14/21
|
4/24/22
|
4/24/23
|
4/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q2
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
-20.34
|
Net margin
|
-
|
EPS
2 |
-0.0620
|
Dividend per Share
|
-
|
Announcement Date
|
8/21/23
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-9.06%
|
11.5%
|
14.1%
|
11.1%
|
-11.7%
|
6.49%
|
16.4%
|
12.1%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
7.67%
|
7.01%
|
-
|
3%
|
8.85%
|
5.4%
|
Assets
1 |
-
|
-
|
2,265
|
2,636
|
-
|
3,435
|
4,929
|
4,278
|
Book Value Per Share
2 |
-
|
-
|
4.840
|
5.290
|
4.530
|
4.840
|
7.290
|
5.800
|
Cash Flow per Share
2 |
-
|
-
|
0.4700
|
0.2100
|
-0.6100
|
1.110
|
1.750
|
1.120
|
Capex
1 |
-
|
-
|
84.6
|
215
|
229
|
250
|
562
|
250
|
Capex / Sales
|
-
|
-
|
5.54%
|
13.41%
|
17.08%
|
13.43%
|
15.01%
|
8.15%
|
Announcement Date
|
4/23/20
|
4/14/21
|
4/24/22
|
4/24/23
|
4/12/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -.--% | 561M | | +17.80% | 66.73B | | +2.92% | 49.79B | | +19.98% | 42.5B | | +20.88% | 26.45B | | +12.04% | 19.66B | | +1.27% | 17.18B | | -22.98% | 15.82B | | +2.77% | 15.56B | | -9.25% | 15.41B |
Other Specialty Chemicals
|